Sökning: onr:"swepub:oai:gup.ub.gu.se/332385" >
Impact of high-risk...
Impact of high-risk prenatal screening results for 22q11.2 deletion syndrome on obstetric and neonatal management: Secondary analysis from the SMART study
-
Martin, Kimberly (författare)
-
Norton, Mary E. (författare)
-
MacPherson, Cora (författare)
-
visa fler...
-
Demko, Zachary (författare)
-
Egbert, Melissa (författare)
-
Haeri, Sina (författare)
-
Malone, Fergal (författare)
-
Wapner, Ronald J. (författare)
-
Roman, Ashley S. (författare)
-
Khalil, Asma (författare)
-
Faro, Revital (författare)
-
Madankumar, Rajeevi (författare)
-
Strong, Noel (författare)
-
Silver, Robert (författare)
-
Vohra, Nidhi (författare)
-
Hyett, Jon (författare)
-
Kao, Charlly (författare)
-
Hakonarson, Hakon (författare)
-
- Jacobsson, Bo, 1960 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för obstetrik och gynekologi,Institute of Clinical Sciences, Department of Obstetrics and Gynecology
-
Dar, Pe'er (författare)
-
visa färre...
-
(creator_code:org_t)
- 2023
- 2023
- Engelska.
-
Ingår i: Prenatal Diagnosis. - 0197-3851 .- 1097-0223. ; 43:13, s. 1574-1580
- Relaterad länk:
-
https://gup.ub.gu.se...
-
visa fler...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Objective: One goal of prenatal genetic screening is to optimize perinatal care and improve infant outcomes. We sought to determine whether high-risk cfDNA screening for 22q11.2 deletion syndrome (22q11.2DS) affected prenatal or neonatal management. Methods: This was a secondary analysis from the SMART study. Patients with high-risk cfDNA results for 22q11.2DS were compared with the low-risk cohort for pregnancy characteristics and obstetrical management. To assess differences in neonatal care, we compared high-risk neonates without prenatal genetic confirmation with a 1:1 matched low-risk cohort. Results: Of 18,020 eligible participants enrolled between 2015 and 2019, 38 (0.21%) were high-risk and 17,982 (99.79%) were low-risk for 22q11.2DS by cfDNA screening. High-risk participants had more prenatal diagnostic testing (55.3%; 21/38 vs. 2.0%; 352/17,982, p<0.001) and fetal echocardiography (76.9%; 10/13 vs. 19.6%; 10/51, p<0.001). High-risk newborns without prenatal diagnostic testing had higher rates of neonatal genetic testing (46.2%; 6/13 vs. 0%; 0/51, P<0.001), echocardiography (30.8%; 4/13 vs. 4.0%; 2/50, p=0.013), evaluation of calcium levels (46.2%; 6/13 vs. 4.1%; 2/49, P<0.001) and lymphocyte count (53.8%; 7/13 vs. 15.7%; 8/51, p=0.008). Conclusions: High-risk screening results for 22q11.2DS were associated with higher rates of prenatal and neonatal diagnostic genetic testing and other 22q11.2DS-specific evaluations. However, these interventions were not universally performed, and >50% of high-risk infants were discharged without genetic testing, representing possible missed opportunities to improve outcomes for affected individuals.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Reproduktionsmedicin och gynekologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Obstetrics, Gynaecology and Reproductive Medicine (hsv//eng)
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Martin, Kimberly
-
Norton, Mary E.
-
MacPherson, Cora
-
Demko, Zachary
-
Egbert, Melissa
-
Haeri, Sina
-
visa fler...
-
Malone, Fergal
-
Wapner, Ronald J ...
-
Roman, Ashley S.
-
Khalil, Asma
-
Faro, Revital
-
Madankumar, Raje ...
-
Strong, Noel
-
Silver, Robert
-
Vohra, Nidhi
-
Hyett, Jon
-
Kao, Charlly
-
Hakonarson, Hako ...
-
Jacobsson, Bo, 1 ...
-
Dar, Pe'er
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Reproduktionsmed ...
- Artiklar i publikationen
-
Prenatal Diagnos ...
- Av lärosätet
-
Göteborgs universitet